Evidence map›Paper›PMID 31043657›Full record

Trial reportScientific reports2019

Effects of Burdock tea on recurrence of colonic diverticulitis and diverticular bleeding: An open-labelled randomized clinical trial.

Akira Mizuki, Masayuki Tatemichi, Atsushi Nakazawa, Nobuhiro Tsukada, Hiroshi Nagata, Yoshikazu Kinoshita

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Akira MizukiDepartment of Internal Medicine, Keiyu Hospital, Yokohama, Japan. amizuki2@yahoo.co.jp.ORCID http://orcid.org/0000-0002-3217-5177
Masayuki TatemichiDepartment of Preventive Medicine, Tokai University School of Medicine, Isehara, Japan.
Atsushi NakazawaDepartment of Internal Medicine, Saiseikai Central Hospital, Tokyo, Japan.
Nobuhiro TsukadaDepartment of Internal Medicine, Saiseikai Central Hospital, Tokyo, Japan.
Hiroshi NagataDepartment of Internal Medicine, Keiyu Hospital, Yokohama, Japan.
Yoshikazu KinoshitaDepartment of Gastroenterology and Hepatology, Shimane University School of Medicine, Izumo, Japan.
keiyu Hospital · JPSaiseikai Central Hospital · JPShimane University · JPTokai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Colonic diverticular bleeding (CDB) and acute colonic diverticulitis (ACD) show high recurrence rates. The establishment of optimal strategies that prevent the recurrence of CDB and ACD is a major concern among gastroenterologists. This study aimed to assess the efficacy of burdock tea for preventing CDB and ACD recurrences. Newly diagnosed patients with CDB (n = 91) or ACD (n = 70) were randomly assigned into two groups. The experimental group received 1.5 g of burdock tea three times a day, whereas the control group did not receive any treatment. The median (interquartile range) of observation for recurrence of CDB or ACD was 22.0 (14.1) months and 30.3 (18.6), respectively. The burdock tea treatment showed significant preventive effects on recurrence of ACD. A lower ACD recurrence rate (5/47 [10.6%] vs. 14/44 [31.8%]) and longer recurrence-free duration was observed in the burdock tea group (59.3 months [95% CI: 54.0-64.7] vs. 45.1 months [95% CI: 37.1-53.0] by the Kaplan-Meier analysis; p = 0.012 by log rank test) than in the control group, although there was no significant preventive effects on the CDB recurrence. This randomized clinical trial demonstrated that daily intake of burdock tea could be an effective strategy for prevention of ACD recurrence, but not for CDB recurrence.

Indexed as

TeaAdultAgedAged, 80 and overDiverticular DiseasesDiverticulitis, ColonicFemaleFollow-Up StudiesGastrointestinal HemorrhageHumansMaleMiddle AgedPrognosisProspective StudiesRecurrenceSurvival RateTea

Identifiers

PMID31043657
PMCPMC6494891
OpenAlexW2942782271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.